Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of levocetirizine vs desloratadine in allergic rhinitis
2004-002823-42Phase 4Completed
- Sponsor
- UCB
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic rhinitis (AR) comparing Levocetirizine 5 mg, Desloratadine 5 mg and Placebo (3 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2005; status: completed.
02
Drugs
levocetirizinedesloratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2004-002823-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002823-42.